Nvidia crushes earnings; stock falls after hours
Okay, if you’re a trader I sort of understand selling Nvidia (NVDA) after today’s earnings report: Sell on the news; How can it get better? How long can the company keep it up? After all, the stock closed today just pennies below it’s all time high....
Diamondback Energy beats on earnings and starts dividend
After the close of New York trading today, Diamondback Energy (FANG) announced fourth quarter earnings of $1.56 a share (excluding one-time items). That beat the Wall Street consensus by 5 cents a share. Revenue climbed 116% year over year to $399 million, above...
Autoliv earnings beat and spinoff plans buck yesterday’s market plunge
While the Standard & Poor’s 500 stock index was falling 1.04% yesterday and the Dow Jones Industrial Average was giving up 362 point, auto safety supplier Autoliv (ALV) was busy climbing 8.07% on the day to close at $149.48. (The stock, a member of my Jubak...
Apple gets a two-pronged roasting and the stock stumbles
Apple (AAPL) is getting hit from two directions in the closing days of 2017. On the negative news Apple fell 2.5% yesterday, December 26. The shares rebounded very slightly–0.02%–today. The first bad news came yesterday as analysts cut their estimates for...
Lithium producer SQM soars after Chilean election
Quite a good two days for Sociedad Quimica y Minera de Chile or SQM for short. The Chilean producer of lithium climbed almost 8% yesterday and tacked on another 2.8% today. The shares (SQM) are now up 11.47% since I added them to my long-term 50 Stocks Portfolio back...
It’s beginning to look a lot like Christmas in Macao–and for MGM Resorts
The first ten days of December have been strong for gaming revenue in Macao. That has led investment company Sanford Bernstein to project that gaming revenue in Macao will climb 21% to 23% for the month. That would be stronger than expected–and bodes well for...
One less competitor for Corning in optical fiber
Corning (GLW) will buy the Communication Markets Division of 3M (MMM) for $900 million. The 3M division has approximately $400 million in annual sales of high bandwidth and optical fiber products. Corning expects the acquisition to add 7 cents to 9 cents to its fiscal...
A reminder of why Jubak Pick Incyte has been so weak lately
On December 4 MacroGenics (MGNX) announced that it had closed on its previously announced (October 25) license agreement with Incyte (INCY). For an upfront payment of $150 million and up to $420 million in milestone payments Incyte gained the exclusive global rights...
Visa beats on earnings and revenue as payment volumes climb by 9.8%
Today October 25 Visa (V) reported September quarter earnings of 90 cents a share, 5 cents a share above Wall Street projections. Revenue climbed 13.9% year over year to $4.86 billion vs. Wall Street projections of $4.63 billion. Â Payments volume, on a constant...
Xylem raises guidance for fiscal 2017 after slight earnings beat in second quarter
On August 1 Xylem (XYL) reported second quarter earnings of 59 cents a share (excluding one-time items), beating Wall Street earnings estimates by 2 cents a share. Thanks to recent acquisitions revenue of $1.16 billion climbed 24.9% year over year, slightly missing...
Day 2 for Apple earnings leads to some market concern
Apple (AAPL) shares soared on Wednesday after the company announced December quarter earnings. And there was sure a lot to cheer about as I noted in my post on Apple’s results yesterday. The shares closed up $5.15 to $129. Today, though, was a day for mulling...
Vale sells fertilizer assets to Mosaic–time for this long-term stock pick to pay down some debt
Brazil’s Vale (VALE) has agreed to sell it fertilizer assets to Mosaic (MOS) for $2.5 billion in cash and stock. The price at 15 times trailing-12-month EBITDA (earnings before taxes, interest, depreciation, and amortization) is a good one given the continued...
Raising my target price on Jubak Picks Cheniere Energy
Update December 9, 2016 The Cheniere Energy story is pretty simple. The company got the first license to export liquified natural gas from the United States, locked in long-term contracts for its Sabine Pass and Corpus Christi terminals, and then waited for revenue to...
Keeping Corning in my long-term 50 Stocks portfolio but calling shares fully valued after 36% gain year-to-date
Update December 8, 2016. Corning (GLW) is up again today–1.22% on December 8–on news that the company has authorized a $4 billion share buyback. With a gain of 7.2% in the last month and 36.1% year-to-date I think the shares are now fully valued. No need...
Adding Coach to my dividend portfolio; keeping it in long-term 50 Stocks list
And to think that in 2015 I was thinking of dropping Coach (COH) from my long-term Jubak 50 Stocks portfolio. In mid-2015 the stock was languishing at $28.48 (September 25, 2015) and seemed to be floundering with stagnant sales, falling margins, and a loss of pizzazz...
Good news for Ionis pipeline from this trial–upping target price to $65
Sometimes the importance of a clinical trial extends way beyond the specific drug under study. That’s the case with the Phase II data recently released by Ionis for FIXRx. The trial did show efficacy in the treatment of kidney disease. But the most important...
More good news for Jubak Pick Incyte–raising target price to $125
Incyte (INCY) has been one of the big movers in the biotech rally after Donald Trump’s victory in the November 8 presidential election. The stock is up 26.7% from the close on November 3 to the close today, November 17. (Incyte is a member of my Jubak Picks...
Acadia Pharmaceuticals is my first Trump stock pick
The big test for Acadia Pharmaceuticals (ACAD) this quarter certainly wasn’t earnings. As an early stage biotech losses are expected and that’s exactly what the company delivered when it reported third quarter results on November 7. The loss came to 61...
Bristol-Myers continues to make up lost ground after August failure of Opdivo trial
Back on August 8 Bristol-Myers Squibb (BMY) announced that its key immuno-oncology drug Opdivo had failed to demonstrate its efficacy in a trial for treating lung cancer. At the time I characterized this particular trial as a part of a go-for-broke strategy that would...
Can Facebook beat sky-high expectations on November 2? Adding it to my long-term portfolio
How high are expectations for Facebook’s (FB) third quarter earnings report after the close on November 2? The report comes with the stock at an all-time high. (Shares closed at $130.99 on October 31.) Wall Street is looking for 96 cents a share, up from 57...
Finally it’s official: Qualcomm to acquire NXP Semiconductors for $110 a share in cash
Qualcomm (QCOM) and NXP Semiconductors (NXPI) have agreed to a deal that would see a subsidiary of Qualcomm acquire NXP for $110 a share in cash. The structure of the deal will allow Qualcomm to use its offshore cash reserves to help fund the deal, which is expected...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!